Range estimates are from $2.72 to $3.19 per share of AMGN stock. Street expectations imply a very modest increase in profits from the year ago period and mixed results over the last three quarters. Sequentially and compared to Q4, …
Even though Amgen, Inc. (NASDAQ:AMGN) stock has one of the best-performing charts I’ve seen, it doesn’t get the respect it deserves. From a valuation perspective, it sells at a sizable discount to its competitors. Its price-earnings …
AMGN Stock: The Completed Technical Price Pattern Points Towards Higher Stock Prices This time last year, the biotechnology stocks were out of favor and lagging behind the market indices. A lot has changed since then because …
Shares of Amgen, Inc. (NASDAQ:AMGN) have a tight, nicely formed bull flag over the last two weeks on the stock chart. This pattern signals another up-move coming. The upside target is easy to find, a gap fill resistance at $180.00. The …
Shares of biotech giant Amgen, Inc. (NASDAQ:AMGN), while higher by roughly 19% for the year, also remains a pain trade for momentum-chasing traders as well as longer-term investors. Yet, if one looks at the broader large-cap biotech …
As violent as the biotech sector has been for the past twelve months, stocks like Amgen, Inc. (NASDAQ:AMGN) have been resilient in setting new highs. While the range is flat overall, AMGN stock has had several +/- 25% moves in …
Biotech major Amgen Inc. AMGN reported third-quarter 2017 earnings of $3.27 per share, which beat the Zacks Consensus Estimate of $3.09 by 5.8%. Earnings increased 8% from the year-ago period backed by lower operating costs, which …
Large-capitalization biotechnology stocks as represented by the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) lifted on Thursday on the back of comments from the Independent Payment Advisory Board said that …